{'fraction_non_alphanumeric': 0.02218570254724733, 'fraction_numerical': 0.008216926869350863, 'mean_word_length': 5.278350515463917, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
B cell activation regulates exosomal HLA production

Exosomes are nanovesicles produced constitutively and inducibly by several types of cells. They are generated as intraluminal vesicles of multivesicular bodies and express MHC and several endosomal/lysosomal proteins. In spite of their potential role in cellular immunity, the regulatory mechanisms of exosome production are largely unknown. In this study, we have established a novel ELISA system to quantify exosomal HLA using a combination of anti‐HLA class I and anti‐HLA‐DR mAb. We found that exosomal HLA production of B cells was enhanced by contact with CD4+ T cells. Neutralizing anti‐CD154 (CD40L) mAb inhibited this effect, and a soluble CD40L significantly increased production of exosomal HLA in B cells. In addition, B cell stimulation via BCR and TLR9 enhanced their production while IL‐4 stimulation alone failed to do so. Strikingly, an inhibitor of the classical NF‐κB pathway drastically inhibited exosomal HLA production in stimulated B cells, indicating that the classical NF‐κB pathway is critical for exosomal HLA production in B cells. Together, these findings suggest a pivotal role of B cell activation in exosomal HLA production in vivo.